Chinese
Japan
English
ProBio Signs MOU to Form Strategic Partnership with GeneCraft To Development and Production of New AAV gene therapies
ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program
ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs
ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies
ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System
Athenex Partners with Leading Contract Manufacturer ProBio in the Development of Advanced Cell and Gene Therapies
ProBio Signs CDMO Supply Agreement And Forms Strategic Partnership with AffyXell Therapeutics – A Joint Daewong-Avacta Venture
National Cancer Center Japan and ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development
ProBio initiates an Antibody CDMO contract for next-generation CD47 antibody with InnoBation Bio
Successful Groundbreaking Ceremony for ProBio to Expand Commercial cGMP Plasmid and Viral Vector Manufacturing Facility in Zhenjiang, China
ProBio and AbTis Enter into an Exclusive Worldwide License Agreement for ADC Targeting Claudin 18.2
China’s Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, ProBio Expanding Manufacturing Capacity Again
ProBio Named a Top 10 Drug Discovery Solution Provider in Asia-Pacific
ProBio Passed European Union Qualified Person (QP) Audit Successfully
ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea
ProBio and TG ImmunoPharma Enter into Collaboration on Innovative Antibody Drug Project
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII
ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme
SunRock Biopharma and ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program